Published in
American Association for the Advancement of Science, Science Translational Medicine, 402(9), 2017
DOI: 10.1126/scitranslmed.aaf7779
Links
Tools
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes
Journal article published in 2017 by
Mohammad Alhadj Ali 
,
Yuk-Fun Liu ,
Sefina Arif,
Danijela Tatovic,
Hina Shariff ,
Vivienne B. Gibson,
Norkhairin Yusuf,
Roman Baptista ,
Martin Eichmann ,
Nedyalko Petrov ,
Susanne Heck,
Jennie H. M. Yang ,
Timothy I. M. Tree ,
Irma Pujol-Autonell ,
Lorraine Yeo
and other authors.
,
Yuk-Fun Liu ,
Sefina Arif,
Danijela Tatovic,
Hina Shariff ,
Vivienne B. Gibson,
Norkhairin Yusuf,
Roman Baptista ,
Martin Eichmann ,
Nedyalko Petrov ,
Susanne Heck,
Jennie H. M. Yang ,
Timothy I. M. Tree ,
Irma Pujol-Autonell ,
Lorraine Yeo
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Immunotherapy using peptide from the self-antigen proinsulin is safe in type 1 diabetes and is associated with changes in immune regulation.